Pancragen is a peptide bioregulator derived from pancreatic tissue extracts studied for its role in modulating endocrine and exocrine gene expression. It influences peptide-mediated regulation of insulin synthesis and enzymatic activity through transcriptional and receptor-level signaling in preclinical models. Pancragen is used in research investigating pancreatic peptide signaling, metabolic regulation, and cellular homeostasis mechanisms.
For research use only. Not for human consumption.
References:
Khavinson VK et al., Bull Exp Biol Med, 2003 136(1):55–58
Anisimov VN et al., Biochemistry (Moscow), 2000 65(8):901–908
Morozov VG et al., Mech Ageing Dev, 1997 96(1–3):123–132
Pancragen 20mg (Bioregulator)
$65.00
Pancragen is a peptide bioregulator derived from pancreatic tissue extracts studied for its role in modulating endocrine and exocrine gene expression. It influences peptide-mediated regulation of insulin synthesis and enzymatic activity through transcriptional and receptor-level signaling in preclinical models. Pancragen is used in research investigating pancreatic peptide signaling, metabolic regulation, and cellular homeostasis mechanisms.
Related products
AOD9604 6mg
AOD9604 is a modified version of the hGH fragment 176-191 peptide (contains a di-sulfide bridge) and thus a derivative of human growth hormone (hGH). Originally developed as a lipolytic (fat burning) compound, AOD9604 has shown benefit in studies of heart disease, osteoarthritis/cartilage repair, and metabolic syndrome. AOD9604 stimulates lipolysis (the breakdown or destruction of fat) and inhibits lipogenesis in animal studies.
Dihexa (5mg x 60 Capsules = 300mg)
Dihexa is a small peptide-derived compound designed to support cognitive function and brain regeneration. It acts by activating the HGF/c-Met signaling pathway, which plays a critical role in forming new synaptic connections and enhancing neuroplasticity. Dihexa also mimics the action of brain-derived neurotrophic factor (BDNF), a key molecule involved in learning, memory, and neuronal survival. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke. Unlike traditional nootropics or growth factors with poor blood–brain barrier penetration, Dihexa is orally bioavailable and metabolically stable, allowing for targeted CNS effects. Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement. GHRP-2 (5mg x 10), CJC-1295 no DAC (5mg x 10)
GHRP-6 (5mg x 10) Ipamorelin (5mg x 10)
Hexarelin (5mg x 10), CJC-1295 no DAC (5mg x 10)
Ipamorelin (2mg x 10), CJC-1295 no DAC (2mg x 10)
Semaglutide 10
Semaglutide is a widely researched peptide-based compound recognized for its significant role in metabolic regulation and appetite control. It belongs to the class of GLP-1 receptor agonists, which are designed to mimic naturally occurring hormones involved in glucose metabolism and satiety signaling.
TB-500 (Thymosin Beta-4) (43aa) (2mg x 10 Vials = 20mg)
TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.

Reviews
There are no reviews yet.